title: Influences of hemodilution and anticoagulation on antiplatelet P2Y12 therapy: in vitro whole blood perfusion model.
authors.affiliation: Department of Anesthesiology and Intensive CareKyoto Prefectural University of Medicine, Kyoto, Japan.
authors.forename: Satoru
authors.initials: S
authors.lastname: Ogawa
authors.forename: Kazuya
authors.initials: K
authors.lastname: Hosokawa
authors.forename: Kenichi A
authors.initials: KA
authors.lastname: Tanaka
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006438:Hemodilution / Q000379:methods*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D010477:Perfusion; D010879:Piperazines / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D000068799:Prasugrel Hydrochloride; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D058925:Receptors, Purinergic P2Y12 / Q000187:drug effects*; D013876:Thiophenes / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride